Clinical utility of the nuclear-localized AR-V7 biomarker for treatment choice in metastatic castration-resistant prostate cancer

Clinical Utility of the Nuclear-localized AR-V7 Biomarker in Circulating Tumor Cells in Improving Physician Treatment Choice in Castration-resistant Prostate Cancer

European Urology ◽

10.1016/j.eururo.2019.08.020 ◽

2020 ◽

Vol 77 (2) ◽

pp. 170-177 ◽

Cited By ~ 11

Author(s):

Ryon P. Graf ◽

Melanie Hullings ◽

Ethan S. Barnett ◽

Emily Carbone ◽

Ryan Dittamore ◽

...

Keyword(s):

Prostate Cancer ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Clinical Utility ◽

Treatment Choice ◽

Clinical Utility of Circulating Tumour Cell Androgen Receptor Splice Variant-7 Status in Metastatic Castration-resistant Prostate Cancer

European Urology ◽

10.1016/j.eururo.2019.04.006 ◽

2019 ◽

Vol 76 (5) ◽

pp. 676-685 ◽

Cited By ~ 22

Author(s):

Adam Sharp ◽

Jon C. Welti ◽

Maryou B.K. Lambros ◽

David Dolling ◽

Daniel Nava Rodrigues ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Tumour Cell ◽

Splice Variant ◽

Clinical Utility ◽

Castration Resistant ◽

Circulating Tumour Cell ◽

Androgen Receptor Splice Variant

The Comparison of Clinical Utility between Pan-Cancer Panel and Prostate Cancer-Specific Panel for Metastatic Castration Resistant Prostate Cancer

SSRN Electronic Journal ◽

10.2139/ssrn.3924192 ◽

2021 ◽

Author(s):

Liancheng Fan ◽

Yonghong Li ◽

Xiaochen Fei ◽

Yiming Gong ◽

Xinxing Du ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Utility ◽

Castration Resistant ◽

Pan Cancer ◽

Cancer Panel

Reply to Tuomas Mirtti and Tero Aittokallio's Letter to the Editor re: Fatemeh Seyednasrollah, Mehrad Mahmoudian, Liisa Rautakorpi, et al. How Reliable are Trial-based Prognostic Models in Real-world Patients with Metastatic Castration-resistant Prostate Cancer? Eur Urol. 2017;71:838–40. Clinical Utility of Trial-estimated Prognostic Models

European Urology ◽

10.1016/j.eururo.2017.04.031 ◽

2017 ◽

Vol 72 (3) ◽

pp. e70-e71

Author(s):

Fatemeh Seyednasrollah ◽

Mehrad Mahmoudian ◽

Liisa Rautakorpi ◽

Outi Hirvonen ◽

Tarja Laitinen ◽

...

Keyword(s):

Prostate Cancer ◽

Real World ◽

Clinical Utility ◽

Prognostic Models ◽

Castration Resistant ◽

Letter To The Editor

Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient Selection

OncoTargets and Therapy ◽

10.2147/ott.s315170 ◽

2021 ◽

Vol Volume 14 ◽

pp. 4819-4832

Author(s):

Alexis LeVee ◽

Ching Ying Lin ◽

Edwin Posadas ◽

Robert Figlin ◽

Neil A Bhowmick ◽

...

Keyword(s):

Prostate Cancer ◽

Patient Selection ◽

Clinical Utility ◽

Current Evidence ◽

Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient Selection [Corrigendum]

OncoTargets and Therapy ◽

10.2147/ott.s343977 ◽

2021 ◽

Vol Volume 14 ◽

pp. 5167-5168

Author(s):

Alexis LeVee ◽

Ching Ying Lin ◽

Edwin Posadas ◽

Robert Figlin ◽

Neil A Bhowmick ◽

...

Keyword(s):

Prostate Cancer ◽

Patient Selection ◽

Clinical Utility ◽

Current Evidence ◽

Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancer

Scientific Reports ◽

10.1038/s41598-019-40719-y ◽

2019 ◽

Vol 9 (1) ◽

Cited By ~ 18

Author(s):

Takayuki Sumiyoshi ◽

Kei Mizuno ◽

Toshinari Yamasaki ◽

Yu Miyazaki ◽

Yuki Makino ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Clinical Utility ◽

Receptor Gene ◽

Androgen Receptor Gene ◽

Cell Free Dna ◽

Castration Resistant ◽

Free Dna ◽

Circulating Cell Free Dna

Abstract 4319: Clinical utility of multiplex digital PCR to detect androgen receptor amplification in cell-free DNA for prognosis of metastatic castration-resistant prostate cancer

10.1158/1538-7445.am2020-4319 ◽

2020 ◽

Author(s):

Meijun Du ◽

Chiang-Ching Huang ◽

Winston Tan ◽

Manish Kohli ◽

Liang Wang

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Clinical Utility ◽

Digital Pcr ◽

Cell Free Dna ◽

Castration Resistant ◽

Free Dna

Clinical utility of androgen-receptor splice variant 7 (AR-V7) determinations in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.e17067 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. e17067-e17067

Author(s):

Danilo Piana ◽

Jun Luo ◽

Mark Christopher Markowski ◽

Eugene Shenderov ◽

Emmanuel S. Antonarakis ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Splice Variant ◽

Clinical Utility ◽

Castration Resistant ◽

Androgen Receptor Splice Variant

MP24-15 CLINICAL UTILITY OF DETECTING LOW-FREQUENCY CELL-FREE DNA VARIANTS IN CASTRATION-RESISTANT PROSTATE CANCER

The Journal of Urology ◽

10.1097/ju.0000000000002015.15 ◽

2021 ◽

Vol 206 (Supplement 3) ◽

Author(s):

Kei Mizuno ◽

Shusuke Akamatsu ◽

Takayuki Sumiyoshi ◽

Takayuki Goto ◽

Takashi Kobayashi ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Utility ◽

Low Frequency ◽

Cell Free Dna ◽

Castration Resistant ◽

Free Dna ◽

Dna Variants